TY  - BOOK
AU  - Rath,Santosh Kumar
AU  - Dwibedi,Vagish
AU  - Husen,Azamal
AU  - Akhtar,Nadeem
ED  - SpringerLink (Online service)
TI  - Nanomaterials for Drug Delivery and Neurological Diseases Management
T2  - Smart Nanomaterials Technology,
SN  - 9789819703081
AV  - RA1270.N36 
PY  - 2024///
CY  - Singapore
PB  - Springer Nature Singapore, Imprint: Springer
KW  - Nanomedicine
KW  - Nervous system
KW  - Radiography
KW  - Nanoparticles
KW  - Nanomedicine and Nanotoxicology
KW  - Neuroradiology
N1  - Nanomaterials and Nanocarriers: Basic Properties -- Inorganic, Organic and Polymer-Based Nanomaterials -- Fundamentals of Drug Delivery -- Smart development of nanomaterials and Nanomedicine Formulations -- Nanomaterials and Neurological Disorders Management -- Nanoparticle-based treatment of Central Nervous System (CNS) Diseases -- Nanomaterials for diagnosis and treatment of common neurological disorders -- Biodegradable Nanocarries and disease management -- Targeted nano based drug delivery in Alzheimer's Disease and Dementia -- Nanomaterials as drug delivery vehicles for therapy of Parkinson's Disease -- The use of microbial nanoparticle to treat neurodegenerative disorders -- Aspects of nanomedicines' safety and nanotoxicity for brain-targeted drug delivery
N2  - This book gives a complete overview of current developments in the nano drug delivery technology in the management of neurological disorders and brain diseases. The book is divided into three main sub-sections: A) Fundamental study on nanomaterials, nanocarriers, and nanoformulation-based drug delivery in neurological diseases management, B) Nano drug delivery therapy - a novel approach towards common neurological disorders and C) Novel nano delivery strategies in targeted neurological diseases management. This collective work presents diverse nano-based drug delivery technologies that are high-throughput, reliable, pioneering, and applicable to researchers of different countries despite their socio-economic conditions. It hopefully encourages researchers, innovators and policymaker to adapt nanomaterial-based drug delivery vehicles technologies using diverse nano-based formulation techniques as targeted therapy for treating and managing neurological disorders
UR  - https://doi.org/10.1007/978-981-97-0308-1
ER  -